Natural killer T cells (NKT) are a special class of lymphocytes that recognize lipid antigens presented by CD1 family molecules. They are strongly conserved throughout mammalian evolution. Nonetheless, we do not understand what essential function(s) lipid specific T cells serve to promote the health of the species. To determine if there is a common mouse microorganism that NKT cells play a role in protection from, we co- housed CD1d deficient mice with pet store mice, which bear a relatively high natural microbial burden, to permit physiological transmission of microbes. Adult CD1d deficient mice were generally healthy when co- housed. However, CD1d deficient pups did not survive to term in Cd1d+/- x Cd1d+/- breeding cages where there was normal microbial exposure (i.e. only WT or CD1d heterozygous pups survived). This suggests the hypothesis that NKT cells play a critical role in protecting the developing fetus in the face of diverse microbial infection and may explain their conservation throughout mammalian evolution. This is an exciting new finding and important hypothesis to test. However, key information is required before mechanistic R01 type research can be proposed. In this R21 proposal, we seek to understand whether maternal NKT cells are activated by fetal (trophoblast) CD1d and required for protection of the fetus, and if fetal demise is associated with excess inflammation and/or a specific microbial infection.

Public Health Relevance

Natural killer T cells (NKT) are a special class of lymphocytes that recognize lipid antigens as opposed to peptide antigens that conventional T cells recognize. Preliminary data suggests they are involved in protecting the developing placenta from damage during microbial infection. This research is highly relevant to understanding the evolutionary importance of this lymphocyte subclass. It ultimately may inform what causes miscarriage, growth restriction, and pre-term birth in humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI150158-01A1
Application #
10127367
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Prabhudas, Mercy R
Project Start
2020-11-23
Project End
2022-10-31
Budget Start
2020-11-23
Budget End
2021-10-31
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pathology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455